Article Sidebar
Published:
Mar 6, 2018DOI:
10.4314/tjpr.v17i2.8Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Artemesia annua extract prevents glyoxal-induced cell injury in retinal microvascular endothelial cells during glaucoma
Abstract
Purpose: To investigate the effect of Artemesia annua extract on glyoxal-induced injury in retinal microvascular endothelial cells (HRECs).
Methods: HRECs were cultured in a medium containing 500 μM glyoxal or glyoxal plus 50μM Artemesia annua extract, or in the medium alone for 24 h. Apoptosis was analysed by flow cytometry using annexin V and propidium iodide staining. Changes in mitochondrial membrane potential were determined by JC-1 staining.
Results: When HRECs were cultured in a medium of 500 μM glyoxal, a significant (p < 0.05) decrease in caspase-3 expression was observed. However, treatment of HRECs with Artemesia annua extract (50 μM) inhibited the glyoxal-mediated decrease in caspase-3 expression. The extract also inhibited caspase-3 proteolysis, as was evident from the reduction in the level of cleaved caspase-3. Upregulation of ROS production by glyoxal in HRECs was inhibited by treatment with the extract. The viability of HRECs was significantly decreased by glyoxal (p < 0.05), but the decrease in viability was significantly reversed by Artemesia annua extract (p < 0.05). The extract also reduced gyloxal-induced apoptosis in HRECs from 17.3 to 2.6 % (p < 0.001). Results from JC-1 staining showed significantly (p < 0.001) higher level of green fluorescence in HRECs cultured with glyoxal. However, the glyoxal-induced increase in green fluorescence level was significantly (p < 0.01) reduced on exposure to Artemesia annua extract.
Conclusion: Artemesia annua extract prevents oxidative damage to HRECs via inhibition of ROS production, up-regulation of caspase-3 expression and suppression of caspase-3 proteolysis. Therefore, Artemesia annua can potentially be used for the development of a new drug for the prevention of retinal injury in glaucoma.
Keywords: Artemesia annua, Retinal injury, Glaucoma, Green fluorescence, cleaved caspase-3, ROS production
